Veltuzumab
Abrilumab
Abituzumab
Efalizumab
Caplacizumab
Etaracizumab
Etrolizumab
RGD-4C
Bersanlimab
Ontamalimab
Enlimomab
Volociximab
Tadocizumab
Rovelizumab
Cyclo(Ala-Arg-Gly-Asp-Mamb)
BT200 sodium
RTDLDSLRTYTL
ATN-161
GSK 3008348 hydrochloride
Fradafiban